PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808919
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808919
Hypodermic Syringes and Needles Market size was valued at US$ 6,987.78 Million in 2024, expanding at a CAGR of 3.2% from 2025 to 2032.
The Hypodermic Syringes and Needles Market encompasses devices used for injecting substances into or withdrawing fluids from the body, with significant use in vaccinations, insulin administration, and other medical procedures. The increasing prevalence of chronic diseases such as diabetes, with an estimated 463 million people living with diabetes globally, has spurred demand for insulin delivery devices. The rising number of surgical procedures, coupled with advancements in needle Material, is further boosting the market. On the other hand, the market faces challenges such as the high cost of safety-engineered needles, which are designed to minimize needlestick injuries. However, there are considerable market opportunities arising from the expanding use of prefilled syringes in home healthcare, along with the development of smart syringes that enable real-time monitoring of drug administration.
Hypodermic Syringes and Needles Market- Market Dynamics
Rising Chronic Diseases and Advancements in Injection Technologies Fuel Demand for Hypodermic Syringes and Needles
The growing burden of chronic diseases like diabetes and cancer is significantly increasing the demand for hypodermic syringes and needles, particularly for insulin and chemotherapy drug delivery. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, a figure expected to rise sharply in the coming years, driving large-scale demand for injectable treatments. Similarly, WHO-backed immunization programs, including extensive COVID-19 and HPV vaccination drives, have led to a surge in syringe usage worldwide. Technological advancements such as auto-disable syringes and ultra-fine needles are improving patient compliance and safety, while initiatives by agencies like UNICEF, which procured over 1 billion syringes in 2021 alone for global vaccine distribution, reflect the growing institutional reliance on safe and efficient injection devices.
Hypodermic Syringes and Needles Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.2% over the forecast period (2025-2032)
Based on Product segmentation, Luer Lock was predicted to show maximum market share in the year 2024
Based on Type segmentation, Safety was the leading Type in 2024
Based on Usage segmentation, Disposable was the leading Usage in 2024
Based on Material segmentation, Plastic was the leading Material in 2024
Based on Application segmentation, Drug Delivery was the leading Application in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Hypodermic Syringes and Needles Market is segmented on the basis of Product, Type, Usage, Material, Application, and Region.
The market is divided into two categories based on Product: Hypodermic Syringes (Luer Lock, Luer Slip, Catheter Tip, and Eccentric Tip), and Hypodermic Needles (Standard Needles, Thin-wall Needles, Ultra-fine Needles). Luer Lock syringes dominate due to secure connections in clinical settings, followed by Luer Slip for general use. Among needles, standard needles lead in usage, while ultra-fine needles are rapidly gaining preference in diabetic care, with thin-wall variants used for smoother fluid delivery.
The market is divided into two categories based on Type: Safety (Retractable Safety, Passive Safety, Active Safety), and Non-safety. Safety syringes hold priority due to rising needlestick injury prevention, with retractable safety types most preferred for automatic needle withdrawal. Passive safety follows for ease of use, while active safety types rank lower. Non-safety syringes remain widely used in low-resource settings.
Hypodermic Syringes and Needles Market- Geographical Insights
North America holds a prominent share in the hypodermic syringes and needles market, supported by advanced healthcare infrastructure, high vaccination rates, and rising chronic disease incidence. The U.S. Centers for Disease Control and Prevention (CDC) has consistently funded mass immunization programs, contributing to the demand for safety-engineered syringes. In Europe, government-backed initiatives like the EU4Health program are promoting safe injection practices and stockpiling essential medical supplies, further boosting regional demand. Meanwhile, the Asia-Pacific is witnessing rapid growth due to increasing healthcare access and large-scale immunization drives in countries like India and China. In March 2022, Hindustan Syringes & Medical Devices partnered with the Indian government and UNICEF to supply auto-disable syringes for national vaccination efforts. Additionally, in 2023, Becton, Dickinson and Company (BD) expanded its manufacturing facility in Zaragoza, Spain, to scale up production of injection devices, addressing growing regional and global needs.
The hypodermic syringes and needles market is highly competitive, with key players focusing on capacity expansion, strategic partnerships, and technological innovation. Becton, Dickinson and Company (BD) remains a dominant player, having collaborated with the U.S. government in 2021 to deliver over 286 million syringes for COVID-19 vaccinations. In 2023, Nipro Corporation expanded its manufacturing facilities in Thailand to meet growing global demand, while Terumo Corporation introduced advanced ultra-thin wall needles aimed at improving patient comfort. Smiths Medical, following its merger with ICU Medical in early 2022, strengthened its position in the infusion and injection device segment. Companies like Hindustan Syringes & Medical Devices (HMD) are scaling up exports, supported by partnerships with international health organizations like UNICEF and Gavi. The market is also seeing increased interest in sustainable and smart injection technologies, prompting collaborations focused on eco-friendly materials and needle safety features.
In January 2025, Terumo released its new Injection Filter Needle as the inaugural product under its INFINO(TM) development program. Designed for both hypodermic and intravitreal injections, the needle incorporates a μm polyamide mesh filter and ultra-thin wall cannula to prevent particulate injection, enhancing safety in delicate ocular and systemic drug delivery.
In March 2024, Hindustan Syringes & Medical Devices launched Dispojekt single-use syringes with SIP Shield safety needles to reduce needlestick injuries. With Rs 70 crore investment, HMD targets 200 million units annually, supporting India's Atmanirbhar Bharat medical manufacturing initiative.